BSE Live
Feb 01, 16:01Prev. Close
1595.00
Open Price
1652.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 01, 15:57Prev. Close
1595.30
Open Price
1640.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1610.10 (219)
| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 18.90 | 15.20 | 28.80 | 25.70 | 17.50 | |
| Diluted EPS (Rs.) | 18.90 | 15.20 | 28.80 | 25.70 | 17.50 | |
| Cash EPS (Rs.) | 32.27 | 20.70 | 36.75 | 32.19 | 20.40 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 137.30 | 98.72 | 160.53 | 129.37 | 99.75 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 137.32 | 98.72 | 160.53 | 129.37 | 99.75 | |
| Revenue from Operations/Share (Rs.) | 132.45 | 77.64 | 109.11 | 77.44 | 55.31 | |
| PBDIT/Share (Rs.) | 40.63 | 36.46 | 51.03 | 35.49 | 22.38 | |
| PBIT/Share (Rs.) | 34.86 | 34.49 | 47.78 | 32.68 | 20.40 | |
| PBT/Share (Rs.) | 30.91 | 22.12 | 41.73 | 32.41 | 19.69 | |
| Net Profit/Share (Rs.) | 26.50 | 18.73 | 33.50 | 29.38 | 18.42 | |
| NP After MI And SOA / Share (Rs.) | 21.92 | 15.17 | 28.81 | 25.65 | 17.54 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 30.67 | 46.96 | 46.76 | 45.83 | 40.46 | |
| PBIT Margin (%) | 26.31 | 44.41 | 43.78 | 42.20 | 36.89 | |
| PBT Margin (%) | 23.33 | 28.48 | 38.24 | 41.85 | 35.60 | |
| Net Profit Margin (%) | 20.00 | 24.12 | 30.70 | 37.93 | 33.29 | |
| NP After MI And SOA Margin (%) | 16.54 | 19.53 | 26.39 | 33.12 | 31.70 | |
| Return on Networth/Equity (%) | 17.74 | 16.95 | 19.90 | 21.71 | 19.15 | |
| Return on Capital Employed (%) | 22.09 | 30.54 | 27.89 | 24.42 | 19.85 | |
| Return on Assets (%) | 9.25 | 10.69 | 14.28 | 16.12 | 14.62 | |
| Total Debt/Equity (X) | 0.30 | 0.13 | 0.01 | 0.02 | 0.04 | |
| Asset Turnover Ratio (%) | 0.70 | 0.64 | 0.60 | 0.56 | 0.53 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.78 | 3.12 | 3.76 | 3.93 | 4.30 | |
| Quick Ratio (X) | 1.43 | 2.60 | 2.94 | 3.13 | 3.46 | |
| Inventory Turnover Ratio (X) | 0.95 | 0.79 | 0.84 | 1.04 | 1.16 | |
| Dividend Payout Ratio (NP) (%) | 15.90 | 9.88 | 17.35 | 16.56 | 19.95 | |
| Dividend Payout Ratio (CP) (%) | 12.59 | 8.74 | 15.59 | 14.93 | 17.93 | |
| Earnings Retention Ratio (%) | 84.10 | 90.12 | 82.65 | 83.44 | 80.05 | |
| Cash Earnings Retention Ratio (%) | 87.41 | 91.26 | 84.41 | 85.07 | 82.07 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 14.53 | 170.90 | 122.44 | 130.35 | 31.37 | |
| Interest Coverage Ratios (Post Tax) (%) | 14.53 | 170.90 | 122.44 | 130.35 | 31.37 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 211,177.91 | 115,572.29 | 82,522.91 | 57,036.67 | 44,760.39 | |
| EV/Net Operating Revenue (X) | 7.70 | 7.19 | 7.30 | 7.11 | 7.81 | |
| EV/EBITDA (X) | 25.10 | 15.30 | 15.62 | 15.52 | 19.31 | |
| MarketCap/Net Operating Revenue (X) | 7.72 | 7.38 | 7.50 | 7.35 | 7.99 | |
| Retention Ratios (%) | 84.09 | 90.11 | 82.64 | 83.43 | 80.04 | |
| Price/BV (X) | 8.28 | 6.41 | 5.65 | 4.82 | 4.82 | |
| Price/Net Operating Revenue | 7.72 | 7.38 | 7.50 | 7.35 | 7.99 | |
| Earnings Yield | 0.02 | 0.03 | 0.04 | 0.05 | 0.04 |
01.02.2026
07.01.2026
20.11.2025
12.11.2025
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend